Elevated CD133, but not VEGF or EGFR, as a predictive marker of distant recurrence after preoperative chemoradiotherapy in rectal cancerHiroaki Tanaka(Osaka City University)Oncology ReportsAugust 31, 200910.3892/or_00000491Cited by 48SaveCiteExport RISWatch citationsRelated PapersTransforming growth factor β signaling inhibitor, SB-431542, induces maturation of dendritic cells and enhances anti-tumor activity|Oncology Reports|2010|73